Tuesday, 11 August 2026European Markets

Knowledge Files How We Source Search

#EMA approval

1 article

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

EU Pharmaceutical Regulation

Tafoxiparin Licensing Deal Faces EU Approval Uncertainty as Exeltis Awaits Market Authorization

ViaNews Editorial Team (Europe)•Feb 21, 2026